×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Dr Caroline Bouche, Dr Jean- Marc Classe & Dr Jean-Sébastien Frénel

Intervenants :
Dr Jean-Sébastien Frénel,
Pr Emmanuel Barranger, Centre Antoine Lacassagne, Nice
Pr Roman Rouzier, Institut Curie, Paris
Dr Jean-Marc Classe, Institut de cancerologie de l'ouest, Nantes

Cas n°1 : Cancer du sein Triple négatif apparemment accessible à une chirurgie première…. Est-ce toujours une bonne idée ?
Dr Jean-Sébastien Frénel
 
Cas n°2 : Cancer du sein T1 RH+/HER2- : quelle indication de chirurgie axillaire en fonction du statut N clinique ?
Pr Emmanuel Barranger
 
Cas n°3 : Cancer du sein RH+/ HER2neg de 4 cm : comment pondérer l’indication de traitement systémique ? Place d’une signature génomique.
Pr Roman Rouzier
 
Cas n°4 : Patiente initialement N0, traitée par CNA : quelle chirurgie axillaire après la CNA ?
Dr Jean-Marc Classe
 

 

 
Shooting date : 2024-05-22
Last update : 2024-06-05

Suggestions

Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, February 4th 2025 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, February 4th 2025 from 08am to 09:30am (GMT+1)
New York : Tuesday, February 4th 2025 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, February 4th 2025 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, February 4th 2025 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, February 4th 2025 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, February 4th 2025 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, February 4th 2025 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 5th 2025 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 5th 2025 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 5th 2025 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 5th 2025 from 04am to 05:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2 surexprimé

Share
Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 07am to 09am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 09am to 11am (GMT+1)
New York : Thursday, March 10th 2022 from 12pm to 02pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 02pm to 04pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 05pm to 07pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 09pm to 11pm (GMT+1)
Bangkok : Friday, March 11th 2022 from 12am to 02am (GMT+1)
Shanghai : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Tokyo : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Sydney : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Wellington : Friday, March 11th 2022 from 05am to 07am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
0
Days
0
Hours
0
Minutes
0
Seconds
Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
Honolulu : Wednesday, May 21st 2025 from 06am to 07am (GMT+2)
San Francisco : Wednesday, May 21st 2025 from 09am to 10am (GMT+2)
New York : Wednesday, May 21st 2025 from 12pm to 01pm (GMT+2)
Buenos Aires : Wednesday, May 21st 2025 from 01pm to 02pm (GMT+2)
Reykjavik : Wednesday, May 21st 2025 from 04pm to 05pm (GMT+2)
London / Dublin : Wednesday, May 21st 2025 from 05pm to 06pm (GMT+2)
Paris / Berlin : Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
Istanbul : Wednesday, May 21st 2025 from 07pm to 08pm (GMT+2)
Moscou / Dubaï : Wednesday, May 21st 2025 from 08pm to 09pm (GMT+2)
Bangkok : Wednesday, May 21st 2025 from 11pm to 12am (GMT+2)
Shanghai : Thursday, May 22nd 2025 from 12am to 01am (GMT+2)
Tokyo : Thursday, May 22nd 2025 from 01am to 02am (GMT+2)
Sydney : Thursday, May 22nd 2025 from 03am to 04am (GMT+2)
Wellington : Thursday, May 22nd 2025 from 05am to 06am (GMT+2)

16th SFCO congress

ROOM 1 / Latest developments in the management of patients treated for RH+ breast cancer

Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, March 13th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, March 13th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, March 13th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, March 13th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, March 13th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, March 13th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, March 13th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, March 14th 2024 from 04am to 05:30am (GMT+1)

Prise en charge du cancer HER2+ métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up